Acute liver failure in children and adolescents

Pediatric and Adolescent Medicine

Volumn 16, Issue , 2012, Pages 14-29

  Shanmugam, Naresh P ^a   Bansal, Sanjay ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870186358     PISSN: 10175989     EISSN: 16623886     Source Type: Book Series    
DOI: 10.1159/000332064     Document Type: Article

References (38)

1. Trey C, Davidson CS: The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-298.
2. Bhaduri BR, Mieli-Vergani G: Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996;16:349-355. (Pubitemid 27074777)
3. Squires RH Jr, Shneider BL, Bucuvalas J, et al: Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-658.
4. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP: Population-based surveillance for acute liver failure. Am J Gastroenterol 2007;102:2459-2463. (Pubitemid 47631759)
5. Ciocca M, Ramonet M, Cuarterolo M, Lopez S, Cernadas C, Alvarez F: Prognostic factors in paediatric acute liver failure. Arch Dis Child 2008;93:48-51.
6. Krawczynski K, Kamili S, Aggarwal R: Global epidemiology and medical aspects of hepatitis E. Forum (Genova) 2001;11:166-179. (Pubitemid 34272521)
7. Bhatia V, Singhal A, Panda SK, Acharya SK: A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008;48:1577-1585.
8. Beath SV, Boxall EH, Watson RM, Tarlow MJ, Kelly DA: Fulminant hepatitis B in infants born to anti-HBe hepatitis b carrier mothers. BMJ 1992;304:1169-1170.
9. Larrey D: Hepatotoxicity of drugs and chemicals. Gastroenterol Clin Biol 2009;33:1136-1146.
10. Davis M: Protective agents for acetaminophen overdose. Semin Liver Dis 1986;6:138-147. (Pubitemid 16010555)
11. Bjornsson E: Review article: Drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 2010;32:3-13.
12. Idilman R, Bektas M, Cinar K, Toruner M, Cerit ET, Doganay B, Erden E, Bozkaya H, Bahar K, Karayalcin S, Soykan I, Palabiyikoglu M, Cetinkaya H, Yurdaydin C, Dokmeci A, Ozden A: The characteristics and clinical outcome of drug-induced liver injury: a single-center experience. J Clin Gastroenterol 2010;44:e128-e132.
13. Ghabril M, Chalasani N, Bjornsson E: Druginduced liver injury: a clinical update. Curr Opin Gastroenterol 2010;26:222-226.
14. Andrade RJ, Robles M, Fernandez-Castaner A, Lopez-Ortega S, Lopez-Vega MC, Lucena MI: Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol 2007;13:329-340. (Pubitemid 46178965)
15. Bosch AM, Waterham HR, Bakker HD: From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency. Ned Tijdschr Geneeskd 2004;148:80-81. (Pubitemid 38089596)
16. Treem WR, Sokol RJ: Disorders of the mitochondria. Semin Liver Dis 1998;18:237-253. (Pubitemid 28425861)
17. Dhawan A, Mieli-Vergani G: Liver transplantation for mitochondrial respiratory chain disorders: to be or not to be? Transplantation 2001;71:596-598. (Pubitemid 32268058)
18. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G: Wilson's disease in children: 37-year experience and revised king's score for liver transplantation. Liver Transpl 2005;11:441-448. (Pubitemid 40533213)
19. Hardy L, Hansen JL, Kushner JP, Knisely AS: Neonatal hemochromatosis: genetic analysis of transferrin-receptor, H-apoferritin, and L-apoferritin loci and of the human leukocyte antigen class I region. Am J Pathol 1990;137:149-153. (Pubitemid 20229597)
20. Whitington PF, Malladi P: Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr 2005;40:544-549. (Pubitemid 40617178)
21. Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF: Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010;51:2061-2068.
22. Smith SR, Shneider BL, Magid M, Martin G, Rothschild M: Minor salivary gland biopsy in neonatal hemochromatosis. Arch Otolaryngol Head Neck Surg 2004;130:760-763. (Pubitemid 38725052)
23. Kader A, Vara R, Egberongbe Y, Height S, Dhawan A: Leukaemia presenting with fulminant hepatic failure in a child. Eur J Pediatr 2004;163:628-629. (Pubitemid 39362543)
24. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: Hlh-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood and Cancer 2007;48:124-131. (Pubitemid 44958267)
25. Mieli-Vergani G, Vergani D: Autoimmune paediatric liver disease. World J Gastroenterol 2008;14:3360-3367.
26. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G: Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547. (Pubitemid 27106430)
27. Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH: Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155:801-806, e801.
28. Dhawan A, Cheeseman P, Mieli-Vergani G: Approaches to acute liver failure in children. Pediatr Transplant 2004;8:584-588. (Pubitemid 40052359)
29. O'Grady JG, Alexander GJ, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445. (Pubitemid 19192181)
30. Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N: Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11:1073-1079. (Pubitemid 41341756)
31. Polson J, Lee WM: Aasld position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197. (Pubitemid 40593928)
32. Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A: Safety and efficacy of N-acetylcysteine in children with nonacetaminopheninduced acute liver failure. Liver Transpl 2008;14:25-30. (Pubitemid 351167985)
33. Koch A, Trautwein C: N-acetylcysteine on its way to a broader application in patients with acute liver failure. Hepatology 2010;51:338-340.
34. Whitington PF, Hibbard JU: High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-1698. (Pubitemid 39458145)
35. Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, Whitington PF: Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155:566-571.
36. Ashorn M, Pitkanen S, Salo MK, Heikinheimo M: Current strategies for the treatment of hereditary tyrosinemia type I. Paediatric drugs 2006;8:47-54.
37. Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP: Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63:559-569. (Pubitemid 27102626)
38. Faraj W, Dar F, Bartlett A, Melendez HV, Marangoni G, Mukherji D, Vergani GM, Dhawan A, Heaton N, Rela M: Auxiliary liver transplantation for acute liver failure in children. Ann Surg 2010;251:351-356.